VIGIL NEUROSCIENCE INC. - COMMON STOCK
3,1800
14-ноября-24 16:45:00
15 мин. задержка
Акции
-0,1600
-4,79%
Сегодняшний диапазон
3,1400 - 3,3500
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Vigil Neuroscience Announces FDA Has Lifted the Partial Clinical Hold on VGL101
30 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at Stifel 2023 CNS Days
22 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
21 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
02 мар 2023 16:00:00 Источник Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 янв 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
15 дек 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
14 дек 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Vigil Neuroscience to Host ALSP KOL Event on December 6, 2022
28 ноя 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Vigil Neuroscience Reports Third Quarter 2022 Financial Results and Provides Business Update
10 ноя 2022 07:00:02 Источник Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at Upcoming Investor Conferences
07 ноя 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
02 ноя 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
01 ноя 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at 2022 Morgan Stanley Global Healthcare Conference
01 сен 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Vigil Neuroscience Announces $75 Million Private Placement Financing
12 авг 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Vigil Neuroscience Reports Second Quarter 2022 Financial Results and Provides Business Update
08 авг 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at 2022 Wedbush PacGrow Healthcare Virtual Conference
02 авг 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Vigil Neuroscience Strengthens Board of Directors with Appointment of Suzanne Bruhn, Ph.D.
28 июл 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Vigil Neuroscience Expands VGL101 Phase 1 Trial to Australia
07 июн 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at 2022 Jefferies Global Healthcare Conference
01 июн 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Vigil Neuroscience Reports First Quarter 2022 Financial Results and Provides Business Highlights
12 май 2022 07:00:01 Источник Nasdaq GlobeNewswire